Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 821 results for "bristol myers squibb"

Company Update: Bristol-Myers Squibb Company (NYSE:BMY)  Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer
Jutia Group

Bristol-Myers Announces Favorable Phase I/II Opdivo Trial Results

Bristol-Myers Squibb Co. (BMY) on Friday announced results from an interim analysis of CA209-040, a Phase I/II dose-ranging trial evaluating the safety and anti-tumor activity of Opdivo in previously-treated patients with hepatocellular carcinoma or ..., 14 hours ago

73 images for bristol myers squibb

Jutia Group, 2 days ago
One News Page United Kingdom, 2 days ago
Jutia Group, 1 week ago
North, 3 weeks ago, 3 weeks ago
Sky News Australia, 1 month ago
OncLive, 4 weeks ago
Reuters, 3 weeks ago
Look to the Stars, 1 month ago, 4 weeks ago

BMS Opdivo improves lung cancer survival

Two Phase III trials have found Opdivo improves lung cancer survival A Phase III trial of Bristol-Myers Squibb's immunotherapy Opdivo has found it increases overall survival in people with a common form of lung cancer. The CHECKMATE-057 ...
 Pharmafile11 hours ago Bristol-Myers Squibb's PD-1 inhibitor Opdivo prolongs survival in Phase III study of lung cancer  FirstWord Pharma12 hours ago Bristol's Opdivo cuts risk of lung cancer death for some  Sharenet12 hours ago Bristol's Opdivo reduces risk of death from common lung cancer  CNBC14 hours ago

Bristol-Myers slumps 7% on less-than-expected Opdivo results in lung cancer study

News Editor Bristol-Myers Squibb (NYSE:BMY) stumbled 7% today on a 4.5x surge in volume in response to the presentation of an abstract (#109) at ASCO that underwhelmed many investors. The data were from Phase 3 study, called CheckMate-057, ...
 Seeking Alpha11 hours ago

Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

B ig pharmas Merck (NYSE: MRK ) and Bristol-Myers Squibb (NYSE: BMY ) released new data on their hot new immunotherapy cancer drugs Friday afternoon, but the results sent their stocks in opposite directions. Bristol's stock dropped 6% after the ...
 Investor's Business Daily12 hours ago

Bristol-Myers Drug Improves Survival in Most Common Lung Cancer

Bristol-Myers Squibb Co.'s newest oncology drug improved survival in patients with the most common form of lung cancer, building the case for wider use of the medicine. In a study of 582 patients with advanced non-squamous, small-cell long cancer ...
 Bloomberg14 hours ago New Bristol-Myers drug improves survival in most common lung-cancer patients  Town Hall12 hours ago

Bristol-Myers sues immunotherapy exec who left for AstraZeneca

Bristol-Myers Squibb has sued a top cancer immunotherapy executive for violating confidentiality and non-compete agreements after he left for direct competitor AstraZeneca (NYSE: AZN - news) , court documents show. The suit, filed in Delaware's ...
 Yahoo! UK and Ireland13 hours ago

Today's Water-Logged And Getting Wetter Stock: Bristol-Myers Squibb Company (BMY)

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified ...
 TheStreet.com14 hours ago

5 pharma plays on Bristol's rough day

Bristol-Myers Squibb's battering after a disappointing drug trial serves as a buying opportunity, "Fast Money"
 Town Hall10 hours ago Trading pharma: 5 plays on Bristol's rough day  Yahoo! Finance8 hours ago

Calls stacking up in Bristol-Myers

Bristol-Myers Squibb attracted bullish option activity yesterday for the second time this week. optionMONSTER's Heat Seeker system detected the purchase of about 1,500 June 71.50 calls for $0.81 in volume well above open interest, showing that this ...
 Option Monster23 hours ago

Bristol-Myers Squibb discloses expiry of USD500m cash tender offer

Biopharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) reported on Wednesday the expiry of its cash tender offer for up to USD500m aggregate principal amount of certain of its outstanding debt securities. The company said its cash tender ...
 Individual.com1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
Get updated on latest news & your favorite topics right in your inbox!
More     Less